A Phase 2, Multicenter Study of the Effect of the Addition of SNDX-275 to Continued Aromatase (AI) Inhibitor Therapy in Postmenopausal Women with ER+ Breast Cancer Whose Disease is Progressing

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Phase 2, Multicenter Study of the Effect of the Addition of SNDX-275 to Continued Aromatase (AI) Inhibitor Therapy in Postmenopausal Women with ER+ Breast Cancer Whose Disease is Progressing
StatusFinished
Effective start/end date15/09/08 → 14/09/11

Funding

  • Queen Elizabeth Hospital Birmingham